Sanofi Announces $20 Billion U.S. Investment Plan Through 2030
Sanofi, the French pharmaceutical giant, has announced plans to invest at least $20 billion in the United States by 2030. The commitment includes a major boost to research and development spending, as well as billions allocated toward expanding U.S.-based manufacturing operations. The move aligns with broader industry trends, following similar investments announced by Roche, Johnson […]
Continue Reading